173 related articles for article (PubMed ID: 17428784)
41. Synthesis of stereospecifically deuterated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) iastereomers and metabolism by A/J mouse lung microsomes and cytochrome p450 2A5.
Jalas JR; Hecht SS
Chem Res Toxicol; 2003 Jun; 16(6):782-93. PubMed ID: 12807362
[TBL] [Abstract][Full Text] [Related]
42. Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.
D'Agostino J; Zhang X; Wu H; Ling G; Wang S; Zhang QY; Liu F; Ding X
Drug Metab Dispos; 2008 Nov; 36(11):2316-23. PubMed ID: 18669584
[TBL] [Abstract][Full Text] [Related]
43. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.
Chung CJ; Pu YS; Shiue HS; Lee HL; Lin P; Yang HY; Su CT; Hsueh YM
Toxicol Lett; 2013 Jan; 216(1):16-22. PubMed ID: 23142425
[TBL] [Abstract][Full Text] [Related]
44. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells.
Yang XJ; Lu HY; Li ZY; Bian Q; Qiu LL; Li Z; Liu Q; Li J; Wang X; Wang SL
Toxicology; 2012 Oct; 300(3):138-48. PubMed ID: 22743290
[TBL] [Abstract][Full Text] [Related]
45. CYP2A6 polymorphisms and risk for tobacco-related cancers.
Rossini A; de Almeida Simão T; Albano RM; Pinto LF
Pharmacogenomics; 2008 Nov; 9(11):1737-52. PubMed ID: 19018727
[TBL] [Abstract][Full Text] [Related]
46. Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers.
von Weymarn LB; Chun JA; Hollenberg PF
Carcinogenesis; 2006 Apr; 27(4):782-90. PubMed ID: 16364922
[TBL] [Abstract][Full Text] [Related]
47. Inhibitory potency of 8-methoxypsoralen on cytochrome P450 2A6 (CYP2A6) allelic variants CYP2A6 15, CYP2A6 16, CYP2A6 21 and CYP2A6 22: differential susceptibility due to different sequence locations of the mutations.
Tiong KH; Mohammed Yunus NA; Yiap BC; Tan EL; Ismail R; Ong CE
PLoS One; 2014; 9(1):e86230. PubMed ID: 24475091
[TBL] [Abstract][Full Text] [Related]
48. Structure, function, regulation and polymorphism of human cytochrome P450 2A6.
Di YM; Chow VD; Yang LP; Zhou SF
Curr Drug Metab; 2009 Sep; 10(7):754-80. PubMed ID: 19702528
[TBL] [Abstract][Full Text] [Related]
49. Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13.
Shimada T; Takenaka S; Murayama N; Kramlinger VM; Kim JH; Kim D; Liu J; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
Xenobiotica; 2016; 46(3):211-24. PubMed ID: 26247835
[TBL] [Abstract][Full Text] [Related]
50. CYP2A6: genetics, structure, regulation, and function.
Raunio H; Rahnasto-Rilla M
Drug Metabol Drug Interact; 2012 May; 27(2):73-88. PubMed ID: 22706231
[TBL] [Abstract][Full Text] [Related]
51. The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract.
D'Agostino J; Zhuo X; Shadid M; Morgan DG; Zhang X; Humphreys WG; Shu YZ; Yost GS; Ding X
Drug Metab Dispos; 2009 Oct; 37(10):2018-27. PubMed ID: 19608696
[TBL] [Abstract][Full Text] [Related]
52. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage.
Yang X; Zhang Z; Wang X; Wang Y; Zhang X; Lu H; Wang SL
Toxicol Appl Pharmacol; 2013 Jul; 270(2):114-21. PubMed ID: 23602888
[TBL] [Abstract][Full Text] [Related]
53. An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population.
Liu T; Hong Y; Li Z; Hong J; Zeng S; Zheng M; Chen S
Drug Metab Dispos; 2012 May; 40(5):847-51. PubMed ID: 22315333
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human cytochromes P450 2A6 and 2A13 by flavonoids, acetylenic thiophenes and sesquiterpene lactones from Pluchea indica and Vernonia cinerea.
Boonruang S; Prakobsri K; Pouyfung P; Srisook E; Prasopthum A; Rongnoparut P; Sarapusit S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1136-1142. PubMed ID: 28856944
[TBL] [Abstract][Full Text] [Related]
55. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1.
Zhang Z; Lu H; Huan F; Meghan C; Yang X; Wang Y; Wang X; Wang X; Wang SL
Int J Cancer; 2014 Apr; 134(7):1539-48. PubMed ID: 24114584
[TBL] [Abstract][Full Text] [Related]
56. Functional characterization of CYP2A13 polymorphisms.
Schlicht KE; Michno N; Smith BD; Scott EE; Murphy SE
Xenobiotica; 2007 Dec; 37(12):1439-49. PubMed ID: 17922361
[TBL] [Abstract][Full Text] [Related]
57. Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model.
Wei Y; Wu H; Li L; Liu Z; Zhou X; Zhang QY; Weng Y; D'Agostino J; Ling G; Zhang X; Kluetzman K; Yao Y; Ding X
Drug Metab Dispos; 2012 Jun; 40(6):1144-50. PubMed ID: 22397853
[TBL] [Abstract][Full Text] [Related]
58. Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.
Chiang HC; Wang CK; Tsou TC
Respiration; 2012; 84(4):319-26. PubMed ID: 22890016
[TBL] [Abstract][Full Text] [Related]
59. Stereospecific deuterium substitution attenuates the tumorigenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Jalas JR; McIntee EJ; Kenney PM; Upadhyaya P; Peterson LA; Hecht SS
Chem Res Toxicol; 2003 Jun; 16(6):794-806. PubMed ID: 12807363
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
Miyazaki M; Yamazaki H; Takeuchi H; Saoo K; Yokohira M; Masumura K; Nohmi T; Funae Y; Imaida K; Kamataki T
Carcinogenesis; 2005 Nov; 26(11):1947-55. PubMed ID: 15958517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
